MDK and hepatocellular carcinoma: Mice with the shRNA-silenced endogenous midkine showed a dramatically lower level of Lv-Gluc in peripheral blood (Figure 4A, p < 0.05), suggesting that midkine functions as a promoter of the anoikis resistant phenotype of HCC cells in vivo to protect from CTC death during circulation.